Glaucoma prevalence in New Zealand is increasing as our population ages, and the country’s public health system is bursting at the seams with the burden. Over the past two decades, various initiatives have evolved to try and tackle this problem head on, but are they making a difference?
Like many things, the O-Show (originally scheduled for May 2020) followed a circuitous path thanks to the pandemic, eventually taking place from 28-29 May 2022 in Sydney’s Hordern Pavilion. But, boy, was it worth the wait!
ZEISS ClearView Finished Single Vision lenses represent a milestone in optics and aesthetics of stock lenses
Pilot evaluation for an image-based eyelid lesion management service
Whilst cataract surgery with phacoemulsification has for many years been recognised to be one of the safest and most effective surgical procedures, there remain several areas where technological advancements could potentially increase surgical success. With the development of their new ZEISS QUATERA
Diabetes has been described as one of the biggest epidemics of the 21st century. By 2045, 783 million people are projected to have developed diabetes globally1. In 2021 alone, diabetes resulted in 6.7 million deaths worldwide and US$966 billion in global healthcare spending1.
I remember when I first looked through a kaleidoscope; it was a magical thing that you pointed towards the light, rotated the end piece and all the shapes and colours exploded. I reckon my brain's going a bit like that.
Have you ever asked yourself if your practice feels safe and welcoming for people from rainbow communities? If you are asking yourself why that would even matter, since you just look at people’s eyes… well, it matters a lot. Rainbow people often delay, or completely stay away from, preventative and
The world of ocular surface health has lately sprawled, owing to a rapid, radical revolution in understanding and practice. How did we get there as a field and, more importantly, how can you get there as a clinician, and keep up?
Ophthalmology New Zealand (ONZ) is the business arm of ophthalmology in New Zealand. In contrast to, and perhaps synergistic with the RANZCO NZ branch, ONZ fulfills a number of critical roles, supported by our overall strategic plan: www.ophthalmologynz.co.nz.
Much like the rest of the world, the Mido Eyewear Show had to endure a two-year hiatus, eventually taking place on 30 April-2 May 2022, belatedly celebrating Mido’s 50th anniversary.
The final Ocular Therapeutics Evening (OTE) of the University of Auckland’s Buchanan Ocular Therapeutics Unit (BOTU) series was held online and focused on paediatric eyecare.